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Peroxiredoxin (Prx), which is a scavenger of 
H2O2 and alkyl hydroperoxides in living orga-
nisms (1), exerts a protective antioxidant role 
in cells through its peroxidase activity, whereby 
H2O2, peroxynitrite, and a wide range of or-
ganic hydroperoxides (ROOH) are reduced and 
detoxifi  ed (2, 3). The mammalian Prx family 
members can be divided into six distinct groups 
(types I through VI) (4). Although diff  erent 
Prx family proteins exhibit distinct tissue and 
organellar distributions (5), they have been 
shown to have strong antioxidant activities 
in vitro (4). In addition to their antioxidant ac-
tivities, Prx’s participate in various biological 
functions, such as cell proliferation, diff  erentia-
tion, apoptosis, gene expression, and intracel-
lular signaling (6–8). Of note, Prx’s have 
received a great deal of attention owing to their 
role in regulating levels of H2O2, which is an 
intracellular signaling molecule that is common 
to many cytokine-induced signal transduction 
pathways (2, 6, 9). Prx I and Prx II are prime 
candidates for regulators of H2O2 signaling 
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Mammalian 2-Cys peroxiredoxin II (Prx II) is a cellular peroxidase that eliminates endog-
enous H2O2. The involvement of Prx II in the regulation of lipopolysaccharide (LPS) signal-
ing is poorly understood. In this report, we show that LPS induces substantially enhanced 
infl  ammatory events, which include the signaling molecules nuclear factor 𝗋B and mito-
gen-activated protein kinase (MAPK), in Prx II–defi  cient macrophages. This effect of LPS 
was mediated by the robust up-regulation of the reactive oxygen species (ROS)–generating 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidases and the phosphorylation of 
p47phox. Furthermore, challenge with LPS induced greater sensitivity to LPS-induced lethal 
shock in Prx II–defi  cient mice than in wild-type mice. Intravenous injection of Prx II–
defi  cient mice with the adenovirus-encoding Prx II gene signifi  cantly rescued mice from 
LPS-induced lethal shock as compared with the injection of a control virus. The administra-
tion of catalase mimicked the reversal effects of Prx II on LPS-induced infl  ammatory 
responses in Prx II–defi  cient cells, which suggests that intracellular H2O2 is attributable, at 
least in part, to the enhanced sensitivity to LPS. These results indicate that Prx II is an 
essential negative regulator of LPS-induced infl  ammatory signaling through modulation of 
ROS synthesis via NADPH oxidase activities and, therefore, is crucial for the 
prevention of excessive host responses to microbial products.
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  initiated by cell-surface receptors, because they are abundant 
in the cytosol and exhibit high affi   nity for H2O2 (Km values 
<20 μM) (10). Indeed, Prx II enhances the activation of 
platelet-derived growth factor (PDGF) receptor and phos-
pholipase Cγ1 in PDGF signaling via the modulation of 
H2O2 (11). Recent studies have indicated that Prx II inhibits 
general immune cell responsiveness, which may be regulated 
by scavenging low levels of reactive oxygen species (ROS) 
(12). However, the specifi  c contribution of Prx II to the reg-
ulation of infl  ammatory and innate immune responses has not 
been elucidated.
LPS is a major recognition marker for the detection of 
Gram-negative bacteria by the host and a powerful initiator 
of the infl  ammatory response to infection. The interactions 
between pathogens and their multicellular hosts are initiated 
by the activation of pathogen recognition receptors, among 
which members of the Toll-like receptor (TLR) family 
recognize specifi   c pathogen-associated molecular patterns. 
TLR4 is involved in the activation of the immune system by 
LPS through the specifi  c recognition of its endotoxic moiety 
(lipid A). This is a critical event in the immune response to 
Gram-negative bacteria as well as in the etiology of endo-
toxic shock (13). The endotoxin shed from an invading 
pathogen can prime host phagocytes for enhanced cellular 
responses (13). In these responses, LPS up-regulates nicotina-
mide adenine dinucleotide phosphate (NADPH) oxidase as-
sembly by inducing fl  avocytochrome b558 translocation from 
the specifi  c granules to the plasma membrane, which results 
in enhanced ROS release (14).
There exists a growing body of evidence that ROS can 
be purposely made within cells to serve as signaling molecules 
(15). ROS are produced in mammalian cells in response to 
the activation of various cell surface receptors (16) and are 
involved in the modulation of diverse  receptor–ligand 
intracellular signaling pathways (17, 18). The intracellu-
lar cytosolic pathways, in turn, regulate a host of transcrip-
tional changes through classical signaling molecules, such 
as the mitogen-activated protein kinases (MAPKs; e.g., 
MAPK, c-Jun N-terminal kinase [JNK], and the p38 
kinase family), depending on cellular redox conditions. In 
addition, several lines of evidence indicate that the activa-
tion of NF-κB can be controlled by ROS, such as super-
oxide and H2O2 (19, 20). It has been demonstrated that the 
proximal events in TLR4 signaling are oxidant dependent 
and that ROS can modulate NF-κB–dependent transcrip-
tion through involvement in early TLR4-mediated cellular 
responses (20).
Major questions persist concerning the function of Prx II 
in the regulation of endotoxin-induced host responses and 
the mechanisms by which Prx II makes a contribution to in-
tracellular ROS signaling in TLR4/LPS-mediated cellular 
activation. In the present report, we demonstrate, using Prx 
II knockout cells and mice, that Prx II is essential for the reg-
ulation of LPS-induced infl  ammatory gene expression and 
for the activation of NF-κB and MAPKs through the modu-
lation of NADPH oxidase activities and ROS signaling. 
Furthermore, we show that the loss of Prx II leads to an in-
creased sensitivity to endotoxemia, which amplifi  es infl  am-
mation and contributes to mortality. Our fi  ndings indicate 
that Prx II is an essential component in the control of normal 
innate infl  ammatory responses through endogenous ROS-
dependent activation of the NF-κB and MAPK pathways.
RESULTS
Prx II negatively regulates the synthesis of H2O2 
in macrophages stimulated with LPS
Prx II has a high affi   nity for H2O2 and eliminates the intracel-
lular H2O2 generated in response to cell stimulation with 
growth factors (5). We investigated whether intracellular H2O2 
synthesis was up-regulated in Prx II−/− macrophages stimu-
lated with LPS. Upon LPS/TLR4 stimulation, Prx II−/− bone 
marrow–derived macrophages (BMDMs) exhibited signifi  -
cantly higher (greater than twofold) levels of H2O2 than Prx 
II+/+ BMDMs. In addition, Prx II−/− BMDMs showed sig-
nifi  cantly higher baseline levels of H2O2 production than Prx 
II+/+ BMDMs, as measured by 2′,7′-dichlorofl  uorescein 
fl  uorescence (Fig. 1). Interestingly, the levels of H2O2 pro-
duction elicited by the TLR2 agonist peptidoglycan (PGN) 
did not diff  er between BMDMs from Prx II+/+ and Prx II−/− 
mice (Fig. 1).
The expression levels of proinfl  ammatory cytokines 
and cyclooxygenase (COX)-2 and the production 
of NO are signifi  cantly elevated in LPS-stimulated 
Prx II−/− macrophages
We also investigated the regulatory role of Prx II in LPS-
induced infl  ammatory responses in BMDMs from Prx II+/+ 
and Prx II−/− mice. Stimulation of BMDMs with 1 μg/ml 
LPS resulted in signifi  cantly higher TNF-α and IL-6 lev-
els (mRNA and protein) in BMDMs from Prx II−/− mice 
compared with Prx II+/+ mice at different time points 
Figure 1.  LPS-induced up-regulation of ROS generation in Prx II–
defi  cient macrophages. Cells were incubated with DCFH-DA in the pres-
ence or absence of 1 μg/ml LPS or 10 μg/ml PGN for 30 min. (left) Live 
cells were washed with serum-free medium and imaged on a confocal 
microscope. (right) Quantitative data for LPS- or PGN-induced DCF fl  uo-
rescence in BMDMs from Prx II+/+ and Prx II −/− mice (n = 4). *, P < 0.05; 
and ***, P < 0.001 compared with WT cell cultures. Bar, 50 μm.JEM VOL. 204, March 19, 2007  585
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(Fig. 2, A and B). We also examined the COX-2 expres-
sion levels of LPS-stimulated BMDMs, as COX-2 is an im-
portant infl  ammatory mediator that is induced by various 
stimuli, including LPS and cytokines (21). The LPS-induced 
expression of COX-2 was substantially enhanced in Prx II–
defi  cient cells as compared with control cells (Fig. 2, C and D), 
which confi  rms that Prx II negatively modulates infl  amma-
tory factor production in response to LPS. LPS stimulation 
also induced higher NO production in Prx II−/− than in 
Prx II+/+ BMDMs. Of note, neither PGN nor the synthetic 
bacterial lipoprotein (BLP) lipopeptide (Pam3Cys-Ser-Lys4-
OH) produced any diff   erences in cytokine production 
between BMDMs from Prx II+/+ and Prx II−/− mice (Fig. 
2 F). LPS induced signifi  cant production of proinfl  amma-
tory cytokines in BMDMs and splenocytes in both dose- and 
time-dependent manners (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20061849/DC1). These re-
sults imply a signifi  cant role for Prx II in the specifi  c control 
of LPS-induced proinfl  ammatory responses in macrophages 
and splenocytes.
Figure 2.  Proinfl  ammatory mediators are up-regulated in Prx II–
defi  cient macrophages. (A and B) BMDMs from Prx II+/+ and Prx II−/− 
mice with the 129/SvJ or C57BL/6 background were stimulated with 
1 μg/ml LPS, and cell lysates and supernatants were harvested at the 
times indicated. Total RNA was assessed by PCR for TNF-α, IL-6, and 
COX-2 mRNA (mice with the C57BL/6 background; A), and protein ex-
pression was measured by ELISA (B). (C and D) BMDMs from Prx II+/+ 
and Prx II−/− mice were stimulated with 1 μg/ml LPS for the times indi-
cated. COX-2 levels were determined by immunoblotting with the 
anti–COX-2 Ab (mice with the C57BL/6 background; C). Immunofl  uorescence 
images for COX-2 in BMDMs are shown (D). Bar, 100 μm. (E) Nitrite lev-
els in response to LPS were measured by the Griess reagent in BMDMs 
from mice with the C57BL/6 background. (F) BMDMs were stimulated 
with 10 μg/ml PGN, 10 μg/ml BLP, or 1 μg/ml LPS, and the supernatants 
were harvested at 18 h. Cytokine production was measured by ELISA. 
Data shown are the mean ± SD of three experiments. *, P < 0.05; and 
***, P < 0.001 compared with WT cell cultures stimulated with LPS. MC, 
media control.586  PEROXIREDOXIN II REGULATES PROINFLAMMATORY RESPONSES TO LPS | Yang et al.
Prx II negatively modulates NF-𝗋B activation 
and the phosphorylation of MAPK pathway 
kinases in response to LPS
The above data (Fig. 2) indicate that Prx II plays a regulatory 
role in LPS-activated signaling cascades (22). Thus, the role 
of Prx II in regulating LPS-induced NF-κB activation was 
addressed using primary mouse macrophages and Raw264.7 
cells transfected with Prx II constructs. The expression level 
of IκBα was dramatically attenuated in Prx II–defi  cient BM-
DMs after LPS treatment for 0–15 min, whereas it was sustained 
to a   certain extent until 120–240 min in WT cells (Fig. 3 A). 
In addition, the phosphorylation of IKKα/β was more 
Figure 3.  Prx II acts as a physiological negative regulator of LPS sig-
naling. (A) BMDMs from Prx II–defi  cient and WT mice were stimulated with 
1 μg/ml LPS, and cell lysates were harvested at the times indicated. Western 
blot analysis was conducted using the anti-IκBα and anti–phospho-IKKα/β 
Abs. The detection of actin in each sample serves as a loading control. 
(B) NF-κB activation was measured by EMSA with 10 μg of nuclear extracts 
of isolated splenocytes from Prx II–defi  cient and WT mice. The specifi  city of 
NF-κB binding was assessed by incubating the nuclear extracts with a 100-fold 
excess of unlabeled specifi  c probe (lanes 5 and 10; C, cold). (C) RAW264.7 
cells were transfected with WT–Prx II, DN–Prx II, or empty vector. After a 
24-h incubation period in normal culture medium, the transfected cells were 
stimulated with LPS at the times indicated. The lysates of 5 × 105 cell equiv-
alents from each transfectant were immunoblotted with the specifi  c Abs, as 
indicated. The same blots were stripped and reprobed with the anti–β-actin 
Ab. (D) The experimental conditions followed the pattern outlined in A. The 
cells were harvested and subjected to Western blot analysis for phosphor-
ylated SAPK/JNK, ERK1/2, and p38 MAPK. The same blots were washed and 
blotted for total MAPKs as the loading controls. Data shown are the mean 
± SD and are representative of three independent experiments that gave 
similar results (top). The bar graph representing mean phospho-MAPK/total 
MAPK protein expression in cytoplasmic extracts of BMDMs was obtained by 
densitometric analysis (see Materials and methods).JEM VOL. 204, March 19, 2007  587
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rapid and higher in Prx II−/− BMDMs from 15 min after LPS 
stimulation than in WT cells (Fig. 3 A). In addition, we per-
formed electrophoretic mobility shift assays (EMSAs) with a 
32P-labeled NF-κB consensus sequence using nuclear extracts 
from LPS-stimulated primary mouse splenocytes. The results 
show a time-dependent increase in NF-κB DNA binding 
activity in nuclear extracts from both cells, although the Prx 
II−/− cells exhibited greater DNA binding activity for NF-κB 
as compared with the WT cells (Fig. 3 B). These fi  ndings 
correlate with those showing diff  erential patterns of degrada-
tion of IκBα and IKKα/β phosphorylation between cells 
from Prx II+/+ and Prx II−/− mice.
We also examined LPS-mediated NF-κB activation in 
Raw264.7 cells transfected with Myc-tagged Prx II–WT and 
Prx II–dominant-negative (DN) constructs or empty vector, 
respectively. Consistent with the fi  ndings in Fig. 3 B, the 
IκBα levels were considerably decreased from the earliest 
time point of measurement, whereas IKKα/β phosphoryla-
tion was substantially increased in Prx II–DN–transfected 
cells, when compared with cells transfected with the empty 
vector (Fig. 3 C). In contrast, IKKα/β phosphorylation was 
totally abrogated, and the IκBα levels were almost consistent 
in Prx II–WT–transfected cells during the 60-min period of 
LPS treatment (Fig. 3 C).
Activation of the MAPK pathways plays an essential role 
in the mediation of macrophage responses to proinfl  amma-
tory stimuli, such as LPS and cytokines (21, 23, 24). There-
fore, we investigated whether Prx II could aff  ect  MAPK 
signaling cascades, including p38 MAPK (p38) and extracel-
lular signal–regulated kinase (ERK) 1/2, during LPS treat-
ment. Notably, the levels of phosphorylation of p38 and 
ERK1/2 were negligible in LPS-stimulated cells transfected 
with the Prx II–WT construct, whereas they were consider-
ably increased in cells transfected with the Prx II–DN con-
struct, as compared with those that carried the empty vector 
(Fig. 3 C). Consistent with the fi  ndings in Fig. 3 C, primary 
BMDMs from Prx II–defi  cient mice showed lower activa-
tion of MAPKs, which included JNK, ERK 1/2, and p38, 
than the primary BMDMs from WT mice, although the 
kinetics of activation during LPS treatment were similar for 
cells for the two types of mice (Fig. 3 D). Other TLR ago-
nists, such as TLR2 (PGN or BLP), TLR3 (poly I:C), or 
TLR9 (CpG-ODN), did not produce any diff  erences in the 
phosphorylated levels of MAPKs between BMDMs from Prx 
II+/+ and Prx II−/− mice (Fig. S2 A, available at http://www
.jem.org/cgi/content/full/jem.20061849/DC1). Similar pat-
terns of MAPK activation were observed for LPS-stimulated 
splenocytes (Fig. S2 B). Therefore, these data demonstrate 
that Prx II plays a key role in regulating NF-κB and MAPK 
activation in response to LPS.
Endogenous ROS induced by NADPH oxidase is specifi  cally 
involved in the LPS-induced activation of MAPK and 
proinfl  ammatory responses of Prx II–defi  cient cells
ROS, whether endogenously produced or exogenously added, 
have been shown to activate critical signaling pathways to 
promote cell activation or growth responses in a growing 
number of cell systems (25, 26). Therefore, we investigated 
the potential contribution of ROS to the activation of MAPK 
and proinfl  ammatory responses using selective ROS inhibitors 
in BMDMs from Prx II+/+ and Prx II−/− mice. Pretreatment 
with 10 and 30 mM of the antioxidant N-acetyl-l-cysteine 
(NAC) signifi  cantly reduced the LPS-mediated activation of 
MAPK and IκBα degradation in cells from both Prx II+/+ 
and Prx II−/− mice (Fig. 4, A and B). Intriguingly, both 
10 and 20 μM of an inhibitor of NADPH oxidase (diphenyl-
ene iodonium [DPI]) and 1 and 10 μM of an inhibitor of 
  mitochondrial electron transfer chain subunit I (rotenone) 
were capable of blocking LPS-induced MAPK and NF-κB 
Figure 4.  Endogenous ROS induced by NADPH oxidase is specifi  -
cally involved in LPS signaling and proinfl  ammatory responses in 
Prx II–defi  cient cells. (A) After preincubation for 30 min with 10 and 
30 mM NAC, 10 and 20 μM DPI, 10 and 100 μM allopurinol, 1 and 10 μM 
rotenone, 100 and 500 μM L-NMMA, or 100 and 500 μM L-NAME, BM-
DMs were stimulated with 1 μg/ml LPS for 30 min. The cells were har-
vested and subjected to Western blot analysis for IκBα, phosphorylated 
ERK1/2, and p38 MAPK. The same blots were washed and blotted for 
β-actin as the loading control. Data shown are representative of three 
independent experiments that gave similar results. (B) The experimental 
conditions followed the pattern outlined in A. Culture supernatants were 
harvested after stimulation with LPS for 18 h, and the TNF-α and IL-6 
expression levels were measured by ELISA. Data shown are the mean 
± SD of three experiments. *, P < 0.05; **, P < 0.01; and ***, P < 0.001 
compared with WT cell cultures stimulated with LPS. MC, media control.588  PEROXIREDOXIN II REGULATES PROINFLAMMATORY RESPONSES TO LPS | Yang et al.
activation in a dose-dependent manner, albeit only in Prx 
II–defi  cient cells (Fig. 4, A and B). On the other hand, pre-
treatment with 10 and 100 μM of a xanthine oxidase inhibi-
tor (allopurinol) or 100 and 500 μM of NO synthase inhibitors 
NG-monomethyl-l-arginine (l-NMMA) and Nω-nitro-l-
arginine methyl ester (l-NAME) did not signifi  cantly modu-
late MAPK activation or IκBα degradation in cells from 
either Prx II+/+ or Prx II−/− mice (Fig. 4 A).
We also examined the eff  ects of various ROS inhibitors 
on the LPS-stimulated proinfl  ammatory cytokine responses 
of BMDMs from Prx II+/+ and Prx II−/− mice. As shown in 
Fig. 4 B, pretreatment with either DPI or rotenone signifi  -
cantly attenuated the LPS-induced secretion of TNF-α and 
IL-6 in Prx II−/− BMDMs but not in WT cells. These data 
suggest that the augmented responses of LPS-induced MAPK 
activation and proinfl  ammatory cytokine release in Prx II–
defi  cient cells are probably mediated via ROS generated by 
NADPH oxidase and the mitochondria.
LPS stimulation induces greater ROS generation and 
activation of NADPH oxidases in Prx II–defi  cient BMDMs 
than in WT BMDMs
The data (Fig. 4) suggest that both NADPH oxidase and the 
generation of superoxide contribute to LPS-mediated infl  am-
matory signaling in Prx II–defi  cient cells. Therefore, we evalu-
ated the superoxide generation and NADPH oxidase activities 
of Prx II+/+ and Prx II−/− cells. BMDMs from Prx II+/+ and 
Prx II−/− mice were labeled with the ROS-sensitive indicator 
dihydroethidium (DHE), and the generation of oxidized fl  uo-
rescent DHE was monitored after LPS stimulation (Fig. 5 A). 
As early as 10 min after LPS simulation, an increase in ROS 
generation was observed in both types of cells, although signifi  -
cantly elevated responses were detected in the Prx II–defi  cient 
cells. The ROS levels remained elevated for several hours, as 
assessed by determinations of DHE fl  uorescence 2, 6, and 18 h 
after LPS stimulation (unpublished data). In addition, this in-
crease in ROS was inhibited by the presence of 10 μM of the 
NADPH oxidase inhibitor DPI (Fig. 5 A).
We also examined whether NADPH oxidase activities 
were diff  erentially modulated in cells from Prx II+/+ and Prx 
II−/− mice in response to LPS stimulation. As shown in Fig. 
5 B, higher levels of NADPH-induced lucigenin chemilumi-
nescence (CL) were detected in Prx II−/− BMDMs than in 
WT cells after stimulation with LPS. We also studied the ef-
fect of transient overexpression of Prx II–DN in RAW264.7 
cells stimulated with LPS; cells that lacked Prx II showed 4.1-
fold higher levels of NADPH-induced lucigenin CL than 
cells that expressed an abundance of Prx II (Fig. 5 C). Signifi  -
cant inhibition of NADPH-induced lucigenin CL was 
recorded after pretreatment with DPI (Fig. 5, B and C).
Phosphorylation of p47phox is one of the key intracellular 
events associated with NADPH oxidase activation, and 
Ser345 phosphorylation plays a functional role in the poten-
tiation of NADPH oxidase activation (27). Therefore, we 
examined the levels of LPS-induced p47Phox phosphorylation 
in the BMDMs and splenocytes of Prx II+/+ and Prx II−/− 
mice using the anti–phospho-Ser345–p47phox antibody (Ab). 
BMDMs were incubated with LPS for 5–40 min, and the 
levels of phosphorylation of Ser345 in p47phox were analyzed 
by Western blot analysis. In the absence of added LPS, weak 
basal phosphorylation of p47Phox was detected, and phosphory-
lation of p47phox peaked after 20 min of LPS stimulation. 
Figure 5.  ROS-generating NADPH oxidase activities are up-
  regulated in Prx II–defi  cient macrophages. (A) DHE fl  uorescence 
image after 10 min of stimulation. (right) Quantitative data shown are the 
mean ± SD of values from fi  ve random fi  elds and are representative of 
two independent experiments. Bar, 50 μm. (B and C) NADPH oxidase ac-
tivity measured by lucigenin luminescence in RAW264.7 cells transfected 
with WT–Prx II, DN–Prx II, or empty vector (B), and in BMDMs from Prx II–
defi  cient and WT mice (C). MC, media control. (D) BMDMs were lysed, and 
proteins from 5 × 105 cells were analyzed by SDS-PAGE and immuno-
blotting with anti–phospho-Ser345–p47phox Ab (p-Ser345) or anti-p47phox 
Ab (p47phox). The Western blots from different experiments were scanned, 
phosphorylated, total p47phox was quantifi  ed by densitometry, and the 
intensity of phosphorylated p47phox was corrected for the amount of 
p47phox. Results shown are the mean ± SD of three experiments. 
*, P < 0.05; **, P < 0.01; and ***, P < 0.001 compared with WT cell cultures.JEM VOL. 204, March 19, 2007  589
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LPS-induced phosphorylation of p47phox was higher in the 
lysates of Prx II–defi  cient cells than in those of WT cells (Fig. 
5 D). Western blots using an Ab directed against p47phox 
showed that equivalent amounts of protein had been loaded 
in the wells. These data suggest that Prx II–defi  cient macro-
phages generate higher levels of ROS in response to LPS 
because of their higher phagocyte oxidase activities.
In vivo function of Prx II during endotoxin-induced 
lethal shock
We performed an in vivo experiment to assess whether Prx 
II defi  ciency aff  ects susceptibility to endotoxic shock. Prx 
II+/+ and Prx II−/− mice were injected i.p. with LPS (10 and 
20 mg/kg body weight), and survival was monitored for 5 d. 
On day 5 after injection, the lower dose had killed 80% of the 
Prx II−/− mice but only 10% of the Prx II+/+mice (Fig. 6 A). 
The higher dose of LPS had killed 100% of the Prx II−/− 
mice and only 35% of the Prx II+/+mice by day 5 after injec-
tion (Fig. 6 A). Consistent with these fi  ndings, the LPS-in-
duced levels of TNF-α, IL-6, and NO were signifi  cantly 
elevated in the sera of Prx II–defi  cient mice (Fig. 6 B). On 
the other hand, there were no remarkable diff  erences in the 
survival rates and cytokine production levels of Prx II+/+ and 
Prx II−/− mice after i.p. injection of Staphylococcus aureus (Fig. 
S3, A and B, available at http://www.jem.org/cgi/content/
full/jem.20061849/DC1). When LPS-induced COX-2 ex-
pression of Prx II+/+ and Prx II−/− mice was examined in 
spleens, the COX-2 expression of Prx II−/− mice was found 
to be substantially higher than that of WT mice (Fig. 6 C). 
On gross examination, the spleens from Prx II−/− mice were 
observed to be larger in size than those from Prx II+/+ mice 
(Fig. S3 C).
Furthermore, an “add-back” rescue experiment was per-
formed using a recombinant adenovirus expression system in 
Prx II+/+ and Prx II−/− mice. After i.v. injection of adeno-
viral vectors that carry the Prx II gene (Ad–Prx II), Prx II was 
expressed in the spleens of the Prx II−/− mice, whereas con-
trol mice injected with mock virus did not express Prx II 
(unpublished data). The reintroduction of Prx II via adeno-
virus delivery signifi  cantly improved survival from 0% in the 
mock virus–injected control mice to 50% in the Ad–Prx II–
injected mice on day 5 (P = 0.002; Fig. 6 D). These results 
demonstrate that Prx II plays an essential role in regulating 
animal sensitivity to endotoxin-induced lethal shock.
Intracellular H2O2 plays an important role in the increased 
responses of Prx II−/− cells to LPS-induced infl  ammation
Based on the aforementioned observations, we investigated 
whether the up-regulated responses to LPS were related to 
increased intracellular H2O2 production in Prx II−/− cells. To 
answer this question, we transduced Prx II−/− cells with ade-
noviral vectors that carry the catalase gene (Ad-CAT) or Ad–
Prx II. H2O2 production was signifi   cantly abrogated in 
BMDMs that were transduced with Ad-CAT or Ad–Prx II, 
both at baseline and after LPS stimulation, as compared with 
BMDMs that were transduced with the control virus (Fig. 7 A). 
Catalase overexpression using adenoviral vectors signifi  -
cantly inhibited LPS-induced MAPK and NF-κB activation 
(Fig. 7 B) and decreased infl  ammatory cytokine release (Fig. 
7 C) in Prx II–defi  cient cells. In addition, the administration 
of the H2O2 scavengers (catalase or pyruvate) reduced, 
whereas the catalase inhibitor (3-amino-1,2,4-triazole) treat-
ment enhanced, the LPS-induced infl  ammatory responses of 
Prx II−/− cells in a dose-dependent manner (Fig. S4, A and 
B, available at http://www.jem.org/cgi/content/full/jem
.20061849/DC1). Further, the administration of catalase 
Figure 6.  Prx II–defi  cient mice show enhanced sensitivity to LPS-
induced lethal shock. (A) LPS (10 and 20 mg/kg body weight) was in-
jected i.p. into WT mice (+/+; n = 10) and Prx II–defi  cient mice (−/−; 
n = 10). Viability was assessed every 2 h for the fi  rst 10 h and every 10 h 
thereafter. There was no further increase in death after 80 h. (B) Serum 
concentrations of TNF-α, IL-6, and NO in WT and Prx II–defi  cient mice 
(n = 10 per group), as measured by ELISA (for TNF-α and IL-6) and by nitrate 
and nitrite colorimetric assay (for NO) 18 h after LPS injection. Results 
shown are the mean ± SD of three experiments (n = 10). *, P < 0.05; 
**, P < 0.01; and ***, P < 0.001 compared with WT mice. (C) COX-2 immuno-
reactivity in spleens from WT and Prx II–deficient mice shows an 
enhanced cytoplasmic signal for COX-2 in Prx II–defi  cient mice 18 h after 
LPS injection. Images are representative spleen sections from fi  ve mice per 
group. Bars: (top) 300 μm; (bottom) 75 μm. (D) i.v. administration of 1011 
Prx II viral particles into Prx II–defi  cient mice (n = 8) signifi  cantly in-
creases the survival rate from a lethal dose of LPS (20 mg/kg body weight) 
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gave signifi  cantly improved survival in Prx II−/− mice 5 d af-
ter LPS challenge (P = 0.03; Fig. S4 C). Collectively, these 
results suggest that increased H2O2 production plays an im-
portant role in LPS-induced infl  ammatory activation in Prx 
II–defi  cient cells.
D  I  S  C  U  S  S  I  O  N 
Accumulating evidence suggests that Prx’s, a family of perox-
idases initially described for their antioxidant capabilities, are 
important factors for the regulation of signaling pathways 
(11, 28). Although studies performed in other laboratories have 
demonstrated roles for Prx’s under various treatment condi-
tions, studies of their roles in the regulation of LPS signaling 
and modulation of infl  ammatory responses are scarce. LPS 
stimulation has been shown to increase ROS in monocytes/
macrophages (19). ROS are key components of postreceptor 
intracellular signaling pathways (29), and activation of the 
NF-κB and MAPK pathways plays a key role in mediating 
macrophage responses to proinfl  ammatory stimuli, such as 
LPS and cytokines (21, 23, 24). The data presented in this 
paper demonstrate that Prx II, which is a ubiquitous, abun-
dant, and highly conserved thioredoxin (TRX) peroxidase, 
plays an essential role in regulating LPS signaling and sensitiv-
ity to endotoxin-induced lethal shock. Importantly, diff  eren-
tial responses to LPS were conserved in Prx II+/+ and Prx 
II−/− cells from two genetically disparate backgrounds (Fig. 
2, A, C, and E; and not depicted).
Recent studies on the roles of 2-Cys Prx’s indicate that 
they not only abrogate the intracellular H2O2 levels that are 
increased by receptor stimulation but that they also suppress 
downstream signaling responses, which include NF-κB tran-
scriptional activity, stress-activated protein kinase (SAPK)/
JNK activity, and apoptosis (30). In the LPS signaling path-
way, ROS regulation of any intermediate steps, including 
TLR4-dependent activation of IL-1 receptor–associated ki-
nase and subsequent TNF-α receptor–associated factor 6–
  induced activation of MAPK kinase kinase family members, 
accounts for the redox sensitivity of the individual MAPKs, 
as well as that of NF-κB (31). The increased LPS-induced 
infl  ammatory responses of Prx II–defi  cient cells appear to be 
linked to the antioxidant activity of Prx II given that the 
overall levels of H2O2 and superoxide were signifi  cantly 
higher in Prx II–defi  cient cells, both at baseline and after LPS 
stimulation, than those in WT cells. In addition, the adminis-
tration of the H2O2 scavenger catalase mimicked the reversal 
eff  ects of Prx II on LPS-mediated infl  ammatory signaling and 
modulated endotoxin-induced lethal shock in Prx II−/− mice 
(Fig. 7, A–C; and Fig. S4). These data strongly suggest that 
intracellular H2O2 is attributable, at least in part, to the in-
creased infl  ammatory responses of Prx II−/− cells to LPS.
ROS, which include H2O2, superoxide anions, and hy-
droxyl radicals (OH), are used as intracellular signaling mole-
cules by pathways that are involved in proliferation, stress 
responses, mating behavior, and apoptosis. Potential sources 
of superoxide anions include the mitochondrial electron 
transport chain, xanthine oxidase, cytochrome P-450 en-
zymes, uncoupled NO synthases, the phagocytic myeloper-
oxidase system, and NADPH oxidases (32). The mitochondrial 
electron transport chain is an important source of ROS, and 
mitochondria are quite susceptible to oxidative damage, 
which can result in enhanced mitochondrial ROS produc-
tion (32, 33). Our data indicate that NADPH oxidase and 
mitochondrion-dependent ROS generation may play im-
portant roles in Prx II regulation of LPS-induced infl  amma-
tory responses in macrophages.
NADPH oxidase activation is one of the important 
sources of ROS in phagocytes, including macrophages, dur-
ing phagocytosis (34). In resting phagocytes, NADPH oxi-
dase is mainly present in unassembled form on the plasma 
membrane or in the cytosol (35). Upon stimulation, the 
cytosolic components p47phox, p67phox, p40phox, and rac2 trans-
locate to the plasma membrane or phagosome/endosome 
membrane and associate with the membrane-bound fl  avocy-
tochrome b to constitute the intact and functioning enzyme 
(36). Finally, this multicomponent enzyme, which is present 
Figure 7.  Intracellular H2O2 plays an important role in the in-
creased sensitivity of Prx II−/− mice to LPS-induced infl  ammatory 
responses. (A) Prx II−/− BMDMs were infected with Ad–Prx II, Ad-CAT 
(catalase), or control adenovirus (mock) at 200 PFU/cell, and the cells were 
incubated with DCFH-DA in the presence or absence of 1 μg/ml LPS for 
30 min. The results are quantitative data for DCF fl  uorescence in the BM-
DMs from Prx II−/− mice (n = 4). *, P < 0.05; and ***, P < 0.001 com-
pared with BMDMs infected with the control virus. (B) The experimental 
conditions followed the protocol outlined in A. The cells were harvested 
and subjected to Western blot analysis for IκBα, phosphorylated ERK1/2, 
p38 MAPK, and SAPK/JNK. The same blots were washed and blotted for 
β-actin as the loading control. Data shown are representative of three 
independent experiments that gave similar results. (C) The experimental 
conditions followed the protocol outlined in A. Culture supernatants were 
harvested after stimulation with LPS for 18 h, and the TNF-α and IL-6 
expression levels were measured by ELISA. Data shown are the mean 
± SD of three experiments. ***, P < 0.001 compared with cell cultures 
infected with the control virus.JEM VOL. 204, March 19, 2007  591
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on the phagosomal membrane, utilizes electrons derived from 
cytosolic NADPH to generate superoxide anion, which sub-
sequently dismutes to H2O2 and results in the formation 
of other radicals that destroy engulfed pathogens (36). In 
NADPH oxidase activation, the phosphorylation of several 
serines of p47phox plays a pivotal role in oxidase activation in 
intact cells (27, 37, 38). Our data show that the phosphoryla-
tion of p47phox is substantially up-regulated in Prx II–null 
cells. These results suggest that increased NADPH oxidase 
activity and excessive ROS generation are involved in the 
up-regulation of LPS-induced inflammation and MAPK 
activation in Prx II–defi  cient macrophages through increased 
p47phox-Ser345 phosphorylation. Although mouse p47phox-
Ser345 is located in a diff  erent sequence than human p47phox-
Ser345, this anti–human Ab recognizes phosphorylated 
p47phox of mouse origin (unpublished data). Recent studies 
have demonstrated that Ser345 is a point of convergence 
used by diff  erent MAPK activities to induce priming of ROS 
production (38). Collectively, our results indicate that Prx II 
attenuates the selective phosphorylation of Ser345 on p47phox, 
which is a novel regulatory mechanism for infl  ammation that 
may represent a target for antiinfl  ammatory therapy.
The observed linkage of increased NADPH oxidase 
activity and p47phox-Ser345 phosphorylation with Prx II 
defi  ciency raises the question as to whether this activation is 
caused by a direct eff  ect of Prx II as a signal regulator down-
stream of TLR4/LPS signaling or an indirect eff  ect that is 
manifested through oxidation/inactivation of the enzymes 
that are involved in the dephosphorylation of several protein 
kinases. Previous studies have demonstrated that Prx II sup-
presses protein tyrosine phosphatase inactivation upon PDGF 
stimulation, leading to site-specifi  c suppression of PDGFR 
signaling (11). In other studies, the modulation of H2O2 by 
Prx II indicates that H2O2 produced in response to stimulation 
of cells with epiderman growth factor or PDGF potentiates 
the accumulation of phosphatidyl inositol-3,4,5-triphosphate 
and subsequent activation of the phosphatidyl inositol 3 
kinase/Akt signaling pathway through oxidation/inactivation 
of PTEN molecules (28). It is possible that Prx II infl  uences 
the modulation of the cellular phosphatase oxidation/inacti-
vation system in response to TLR4/LPS signaling.
It is noteworthy that the other TLR agonists tested in this 
study, with the exception of TLR4/LPS, did not induce dif-
ferent levels of H2O2 production and downstream signaling 
responses in the BMDMs of Prx II+/+ and Prx II−/− mice. In 
addition, there were no signifi  cant diff  erences in the survival 
rates of Prx II+/+ and Prx II−/− mice after i.p. injection with 
S. aureus (Fig. S3, A and B). This phenomenon may be at-
tributable to the selective role of Prx II in TLR4/LPS signal-
ing through the modulation of NADPH-dependent ROS 
generation. Prx proteins are capable of serving as peroxidases 
and involve TRX and/or glutathione as the electron donor 
(39). TRX interacts with apoptosis signal–regulating kinase 1 
(ASK1), which is a mitogen-activated protein 3 kinase and a 
sensor of oxidative stress (39). Previous studies have shown 
that ASK1 is selectively required for LPS-induced MAPK 
activation and that the induction of proinfl  ammatory cytokines 
is dependent on TLR4 but not on any other TLR (40). In 
addition, recent studies have shown that the ROS-dependent 
MAPK activation is based on the ability of reduced TRX to 
bind to and inhibit both ASK1 and the levels of TRX–ASK1 
complex upon oxidation (41). Based on these studies, it is 
possible that TLR4/LPS stimulation specifi  cally alters the oxi-
dation/reduction of TRX–ASK1 complex in association with 
Prx II and makes it available to activate downstream signaling 
targets. Future studies should reveal the precise molecular 
mechanisms by which Prx II regulates the fi   ne control of 
TLR4/LPS signaling in the context of ROS generation.
As there is increasing evidence that the innate response 
can be dramatically infl  uenced by cellular redox factors, a 
better understanding of oxidative regulation of innate immu-
nity could lead to new treatments for sepsis. The increase in 
ROS after LPS challenge has been demonstrated in diff  erent 
models of septic shock using peritoneal macrophages and 
lymphocytes (42, 43). The injection of NAC, which 
decreases the levels of ROS and TNF-α and prevents the 
activation of nuclear translocation of NF-κB, may increase 
mouse survival from lethal endotoxemia (44). In addition, a 
recent report has shown that disruption of nuclear factor–
  erythroid 2–related factor 2 (Nrf2), which is a basic leucine 
zipper transcription factor that regulates redox balance and 
stress responses, dramatically increases mouse mortality from 
endotoxin-induced septic shock (45). Several in vitro and in 
vivo studies have implicated 2-Cys Prx’s as either therapeutic 
targets or diagnostic biomarkers for major diseases. For ex-
ample, a previous study showing the specifi  c involvement of 
Prx II in smooth muscle cell proliferation (11) suggests the 
potential therapeutic use of Prx II for the inhibition of ath-
erogenic lesion progression. In addition, Prx III knockdown 
by RNA interference appears to sensitize cervical cancer cells 
to death receptor– and stress-mediated apoptosis, possibly 
through the disruption of mitochondrial function (46). The 
therapeutic implications of our observations are highlighted 
by the fi  nding that rescue of Prx II function by injection of 
purifi  ed Ad–Prx II increased the survival rate of Prx II−/− 
mice from endotoxic shock. Our data emphasize the essential 
role of Prx II in the regulation of endotoxic shock suscepti-
bility, which could be useful in the development of a novel 
treatment modality for patients with septic peritonitis.
In summary, the present study suggests a novel key role 
for Prx II in regulating LPS-induced activation of signaling 
cascades that are involved in infl   ammatory responses and 
establishes a link between this role and the observed generation 
of ROS and NADPH oxidase activation. We demonstrate 
for the fi  rst time the importance of Prx II in the regulation of 
sensitivity to endotoxic shock and the role of Prx II in 
NADPH oxidase–derived ROS generation within the sig-
naling cascade. Although further studies are needed to eluci-
date the precise mechanisms underlying TLR4-specifi  c 
regulation of ROS and infl  ammatory factor activation, our 
fi  ndings may encourage the design and discovery of Prx II–
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MATERIALS AND METHODS
Mice and cells. All animal-related procedures were reviewed and approved 
by the Institutional Animal Care and Use Committee of the Korea Research 
Institute of Bioscience and Biotechnology. WT and Prx II–defi  cient mice 
with the 129/SvJKist background were maintained under standard labora-
tory conditions on a 12-h light/dark cycle, with free access to food and 
water. Except when specifi  ed otherwise, all of the experiments described in 
this study were performed using mice with the 129/SvJKist background. We 
also maintained WT and Prx II–defi  cient mice with the C57BL/6 back-
ground for some control experiments. All of the animal procedures were 
conducted in accordance with the guidelines of the Institutional Animal 
Care and Use Committee of Chungnam National University. The genotyp-
ing of animals was performed as described previously (47). Mice were used 
for LPS challenge at 8–10 wk of age. The experimental groups were age and 
sex matched. Escherichia coli O26:B6 LPS  (Sigma-Aldrich) was diluted in 
sterile PBS and injected i.p. into the animals.
BMDMs were diff  erentiated for 5–7 d in M-CSF–containing media, as 
described previously (48). The culture medium consisted of DMEM that 
was supplemented with 10% L929 cell-conditioned medium (as a source of 
M-CSF), 10% heat-inactivated FCS, 1 mM sodium pyruvate, 50 U/ml pen-
icillin, 50 μg/ml streptomycin, and 5 × 10−5 M 2-mercaptoethanol. Sple-
nocytes were isolated by mechanical disruption followed by diff  erential 
centrifugation and resuspension in DMEM. The mouse macrophage cell line 
RAW264.7 was purchased from the American Type Culture Collection and 
grown in DMEM/glutamax supplemented with 10% FCS.
Reagents, DNA, and Abs. For the in vitro experiments, LPS from E. coli 
(0111:B4), PGN (Sigma-Aldrich) from S. aureus (Fluka), and poly I:C (GE 
Healthcare) were used. BLP, which is a synthetic bacterial lipopeptide (Pam-
3Cys-Ser-Lys4-OH) derived from the immunologically active N terminus of 
BLP, was purchased from Boehringer. The mouse-specifi  c oligodeoxynu-
cleotide CpG-ODN1668 (5′-TCCATGAC  G  T  T  C  C  T  G  A  T  G  C  T  -3′) was a 
kind gift from S.J. Lee (Seoul National University, Seoul, Korea). The fol-
lowing reagents were purchased from Sigma-Aldrich and were used at the 
indicated concentrations unless specifi  ed otherwise: NAC (10 and 30 mM), 
DPI (10 and 20 μM), allopurinol (10 and 100 μM), rotenone (1 and 10 μM), 
l-NMMA (100 and 500 μM), and l-NAME (100 and 500 μM).
The expression plasmids that encode Myc–Prx II–WT and Myc–Prx 
II–DN (mutant forms a dimer with endogenous Prx II–WT) were generous 
gifts from S.-W. Kang (Ewha Womans University, Seoul, Korea). Cells 
were transfected using Lipofectamine, as indicated by the manufacturer 
(Invitrogen). Specifi   c Abs against ERK1/2, phospho-(Thr202/Tyr204)-
ERK1/2, p38, phospho-(Thr180/Tyr182)-p38, SAPK/JNK, phospho-
(Thr183/Tyr185)-SAPK/JNK, and phospho-IKKα/β were purchased 
from Cell Signaling. Abs reactive with Prx II were obtained from Lab 
Frontier. Abs to IκBα, COX-2, and p47phox were purchased from Santa 
Cruz Biotechnology, Inc. The anti–phospho-(Ser345)-p47phox Ab has been 
described previously (38). The Ab to β-actin was purchased from Sigma-
Aldrich. All other reagents were purchased from Sigma-Aldrich unless 
otherwise indicated.
Enzyme-linked immunosorbent assay, RT-PCR, and Western 
blots. BMDMs were treated as indicated in the fi  gures and processed for 
analysis by sandwich ELISA, RT-PCR, and Western blot, as described pre-
viously (48). For the sandwich ELISA, serum and cell-culture supernatants 
were analyzed for cytokine content using Duoset Ab pairs (R&D Systems) 
for the detection of IL-6 and TNF-α. RT-PCR was performed after total 
RNA was extracted from the cells using TRIzol (Invitrogen). For Western 
blot analysis, Abs to phosphorylated and total p38, SAPK/JNK, ERK1/2, 
and β-actin were used at 1:1,000 dilutions. Specifi  c bands were developed 
by enhanced CL (GE Healthcare).
Immunostaining. COX-2 expression in BMDMs was assessed by fl  uores-
cence microscopy. The cells were plated on glass coverslips. When the cells were 
70–80% confl  uent, they were fi  xed with cold methanol for 10 min at −20°C. 
Fixed cells were washed three times with PBS and blocked by incubation in 
PBS with 3% BSA for 1 h at room temperature. The cells were washed once 
with 0.3% PBS/BSA and incubated overnight at 4°C with the anti–smooth 
muscle α-actin primary Ab (1:100). The coverslips were washed three times 
with PBS and incubated for 1 h at room temperature with a secondary 
Ab that was conjugated to the green fl  uorescent Alexa Flour 488 dye. 
  Immunofl  uorescence images were taken using a confocal laser-scanning 
microscope (FV500; Olympus).
For immunostaining of tissue sections, spleens were fi  xed by infl  ating 
the tissues with neutral-buff  ered formalin and sectioned, and the slides were 
assessed for immunohistochemistry of COX-2 expression, as previously 
described (49).
H2DCFDA and DHE assays. After LPS stimulation, the cells were incu-
bated with either 10 μM H2DCFDA or 2 μM DHE (Invitrogen) for 15 min 
at 37°C in 5% CO2. The cells were collected and washed once with RPMI 
1640 that contained 10 mM Hepes (Invitrogen). The cells were examined 
under a laser-scanning confocal microscope (LSM 510; Carl Zeiss Micro-
Imaging, Inc.). The images were digitized and stored at a resolution of 512 × 
512 pixels. Five groups of cells were randomly selected from each sample, 
and the mean relative fl  uorescence intensity for each group of cells was mea-
sured with a vision system (LSM 510, version 2.3; Carl Zeiss MicroImaging, 
Inc.) and averaged for all the groups. All of the experiments were repeated at 
least three times.
Measurement of NADPH oxidase activity. NADPH oxidase activity 
was measured using the lucigenin CL method described previously (50), 
with some modifi  cations. In brief, the reaction mixture contained 50 mM 
phosphate buff  er (pH 7), 1 mM EGTA, 150 mM sucrose, and 500 μM luci-
genin as the electron acceptor, and either 100 μM NADPH or 100 μM 
NADH as the electron donor. The reaction was initiated by the addition of 
cell homogenate (150–200 μg of protein). Luminescence was monitored on 
a bioluminescence plate.
EMSA. EMSA were performed as described previously (51). In brief, nuclear 
extracts (2 μg of protein content) were incubated with a consensus double-
stranded NF-κB oligonucleotide (5′-AGT T  G  A  G  G  G  G  A  C  T  T  T  C  C  C  A  G  G  -3′; 
Promega) that was end labeled with γ-[33P]ATP (PerkinElmer). The products 
were separated by electrophoresis, as described previously (51).
Adenovirus production. Recombinant replication-defi  cient adenoviruses 
were used in all the experiments. The adenovirus that encodes the Prx II 
cDNA was a gift from S.-W. Kang, and the adenovirus that encodes the cat-
alase cDNA was a gift from K.-J. Lee (Ewha Womans University, Seoul, 
Korea). Large-scale amplifi  cation of adenovirus was performed as previously 
described (52). In brief, HEK293 cells were transfected with adenoviral vec-
tor (multiplicity of infection = 2), and the replicated virus particles were 
concentrated by CsCl gradient ultracentrifugation. Viral titers were deter-
mined as previously described (52). Purifi  ed and concentrated adenoviruses 
that had titers in the range of 109–1011 PFU/ml were suspended in 10 mM 
Tris-HCl (pH 8.), 2 mM MgCl2, and 5% sucrose. For in vivo delivery of 
adenovirus, 8–10-wk-old Prx II−/− mice were injected i.v. with Ad–Prx II 
(1011 viral particles) before 24 h of LPS challenge. Another cohort of Prx 
II−/− mice (n = 8) was injected with mock adenovirus. For in vitro infection 
with adenovirus, the BMDMs were plated at 5 × 105 cells per well in 96-
well tissue culture plates with RPMI 1640 plus 2% FCS medium that con-
tained the recombinant adenovirus at a concentration of 200 PFU per cell, 
according to the method described previously (53).
Statistical analyses. For parametric data, the results are expressed as the 
mean ± SEM and compared with the two-tailed Student’s t test for paired 
samples. For nonparametric data, the results are expressed as the median ± 
quartiles and compared with the Wilcoxon signed rank test. Where indi-
cated, an adjusted Bonferroni correction for multiple comparisons was used 
to reach an overall p-value of <0.05.JEM VOL. 204, March 19, 2007  593
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Online supplemental material. Supplemental materials and methods 
details the preparation of S. aureus and injections and describes reagents, 
DNA, and Abs. Fig. S1 shows the dose-dependent production of TNF-α 
and IL-6 by Prx II+/+ and Prx II −/− BMDMs (A) and splenocytes (B) 
in response to LPS. Fig. S2 shows the MAPK phosphorylation in Prx 
II+/+ and Prx II−/− BMDMs treated with various TLR agonists (A), 
and MAPK phosphorylation and IκBα degradation in LPS-treated Prx 
II+/+ and Prx II−/− splenocytes (B). Fig. S3 shows viability (A) and se-
rum concentrations of infl  ammatory mediators (TNF-α, IL-6, and NO; 
B) in S. aureus–injected Prx II+/+ and Prx II−/− mice, as well as gross 
examination of spleens (C) from Prx II+/+ and Prx II−/− mice after LPS 
injection. Fig. S4 shows the LPS-induced infl  ammatory responses after 
the administration of the H2O2 scavengers or the catalase inhibitor (A 
and B), and viability in catalase-injected Prx II−/− mice after LPS chal-
lenge (C). Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20061849/DC1.
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